The first Charles River Laboratories International trade was made in Q2 2022. Since then Polen Capital bought shares three more times and sold shares on eight occasions. The investor completely sold their stake between Q1 2024 and Q1 2025.
Charles River Laboratories (CRL) has sold its Avian Vaccine Services business to private equity firm Arlington Capital Partners.The business, now AVS Bio, wi...
Zero NPLs on Rs. 14 Billion worth loans in a globally challenging year Colombo, June 30, 2021 Softlogic Finance PLC, a subsidiary of Softlogic Capital the f...